Daily Anesthesiology Research Analysis
Three studies reshape perioperative science: a UK Biobank GWAS implicates GLRA3 in chronic postsurgical pain, a large cohort links frailty to greater intraoperative hypotension burden, and translational human–mouse work connects postoperative delirium with loss of short-chain–fatty-acid–producing gut microbes. Together, they advance precision risk stratification and novel mechanistic targets.
Summary
Three studies reshape perioperative science: a UK Biobank GWAS implicates GLRA3 in chronic postsurgical pain, a large cohort links frailty to greater intraoperative hypotension burden, and translational human–mouse work connects postoperative delirium with loss of short-chain–fatty-acid–producing gut microbes. Together, they advance precision risk stratification and novel mechanistic targets.
Research Themes
- Genomic determinants of chronic postsurgical pain
- Frailty-driven vulnerability to intraoperative hypotension
- Gut–brain axis mechanisms in postoperative delirium
Selected Articles
1. Genome-wide association study on chronic postsurgical pain in the UK Biobank.
In a UK Biobank GWAS of 95,931 surgical patients, a locus within GLRA3 reached genome-wide significance for chronic postsurgical pain. GLRA3 is implicated in prostaglandin E2 pain pathways, and the authors release summary statistics, while emphasizing the need for external validation.
Impact: This is one of the largest genetic studies of CPSP, revealing a biologically plausible locus and enabling precision pain research. It provides a mechanistic anchor for future target discovery.
Clinical Implications: Immediate practice change is not warranted, but risk stratification tools and PGE2/GLRA3-related pathways may inform future preventive analgesia strategies and trial design.
Key Findings
- GLRA3 showed genome-wide significant association with chronic postsurgical pain in case-control analysis.
- GLRA3 is involved in prostaglandin E2-induced pain processing pathways, supporting biological plausibility.
- Summary statistics are provided to facilitate replication and mechanistic studies; external validation is needed.
Methodological Strengths
- Very large sample size with multiple analytic frameworks (case-control, ordinal, meta-analysis).
- Use of genome-wide significance thresholds and public sharing of summary statistics.
Limitations
- Phenotype definitions rely on postoperative analgesic use and may introduce misclassification.
- Heterogeneity across surgical procedures and lack of independent replication within the study.
Future Directions: Replicate associations in independent, phenotypically rich cohorts; perform fine-mapping, functional assays, and clinical translation for risk prediction and targeted analgesia.
BACKGROUND: Chronic postsurgical pain (CPSP) persists beyond the expected healing period after surgery, imposing a substantial burden on overall patient well-being. Unfortunately, CPSP often remains underdiagnosed and undertreated. To better understand the mechanism of CPSP development, we aimed to identify genetic variants associated with CPSP. METHODS: A genome-wide association study was conducted in a cohort of 95,931 individuals from the UK Biobank who had undergone different surgical procedures. Three analyses were performed: (1) case-control analysis (2923 cases with CPSP and 93,008 controls), (2) ordinal analysis in three groups based on time of analgesics use (n=95,931), and (3) a meta-analysis combining our dataset with a recent publication (n=97,281). RESULTS: In the case-control analysis, one genetic locus within GLRA3 displayed a genome-wide significant (P<2.5×10 CONCLUSIONS: This study contributes new insights into the genetic factors associated with CPSP. The top hit GLRA3 is known for involvement in prostaglandin E2-induced pain processing pathways. Our study provides a foundation for future investigations into the function of these risk variants and the mechanisms underlying CPSP by offering summary statistics. However, further validation in other cohorts is required to confirm these findings.
2. Postoperative delirium after cardiac surgery associated with perioperative gut microbiota dysbiosis: Evidence from human and antibiotic-treated mouse model.
In matched off-pump CABG patients, postoperative delirium was preceded by perioperative gut dysbiosis characterized by reduced alpha diversity, increased Enterococcus, and loss of SCFA-producing genera; fecal SCFAs were reduced and correlated inversely with delirium severity and inflammation. FMT from POD patients induced delirium-like behavior and neuroinflammation in antibiotic-treated mice.
Impact: Provides mechanistic evidence along the gut–brain axis linking microbiome shifts and SCFAs to delirium, including transferable phenotypes in mice. It identifies modifiable targets for perioperative neuroprotection.
Clinical Implications: Supports exploration of microbiome-informed risk stratification and preventive strategies (e.g., preserving SCFA producers, nutrition, antibiotic stewardship) to reduce POD after cardiac surgery.
Key Findings
- Postoperative delirium patients showed lower alpha diversity and distinct microbiota with increased Enterococcus and reduced SCFA-producing genera (e.g., Bacteroides, Ruminococcus).
- Fecal SCFA levels were significantly reduced in POD and inversely correlated with delirium severity and plasma inflammation.
- FMT from POD patients induced delirium-like behavior and neuroinflammation in antibiotic-treated mice, suggesting a transferable microbiome-mediated effect.
Methodological Strengths
- Nested case-control with careful 1:1 matching and longitudinal pre/post fecal sampling.
- Translational validation via FMT into antibiotic-treated mice; SCFA quantification and LEfSe-based microbiome profiling.
Limitations
- Single-center study with modest human sample size (n=60 matched), limiting generalizability.
- Human component is observational; mice were antibiotic-treated rather than germ-free, and causal pathways require further dissection.
Future Directions: Randomized trials testing microbiome/SCFA-preserving interventions, mechanistic dissection of microbial metabolites, and validation across surgical populations.
BACKGROUND: Research links gut microbiota to postoperative delirium (POD) through the gut-brain axis. However, changes in gut microbiota and fecal short-chain fatty acids (SCFAs) in POD patients during the perioperative period and their association with POD are unclear. METHODS: We conducted a nested case-control study among patients undergoing off-pump coronary artery bypass grafting, focusing on POD as the main outcome. POD patients were matched 1:1 with non-POD patients based on sociodemographic characteristics, health, and diet. Fecal samples were collected pre- and post-surgery to assess gut microbiota and SCFAs changes. Postoperative fecal samples were transplanted into antibiotic-treated mice to evaluate delirium-like behavior and neuroinflammation. RESULTS: Out of 120 patients, 60 were matched. Before surgery, gut microbiota in both groups was similar. After surgery, POD patients had lower alpha diversity and distinct microbiota compared to non-POD patients. LEfSe analysis showed POD was linked to increased opportunistic pathogens (Enterococcus) and decreased SCFAs producers (Bacteroides, Ruminococcus, etc.). SCFAs were significantly reduced in POD patients and negatively correlated with delirium severity and plasma inflammation. Mice receiving fecal transplants from POD patients exhibited delirium-like behavior and neuroinflammation. CONCLUSIONS: Postoperative delirium is associated with gut microbiota dysbiosis, marked by an increase in opportunistic pathogens and a decrease in SCFA-producing genera. REGISTRATION: Chinese Clinical Trial Registry ChiCTR2300070477.
3. Influence of frailty status on the incidence of intraoperative hypotensive events in elective surgery: Hypo-Frail, a single-centre retrospective cohort study.
Among 2,495 patients aged ≥70 years, prefrail and frail status increased the rate of intraoperative hypotension by 9% and 16%, respectively, with a 28% increase during induction in prefrail patients. Time-weighted hypotension burden during induction was 15% longer with frailty, supporting targeted optimization and monitoring.
Impact: Quantifies a modifiable hemodynamic risk in a growing surgical population, linking frailty to hypotension burden and informing perioperative pathways.
Clinical Implications: Incorporate frailty screening into preoperative assessment; consider prehabilitation, proactive vasopressor strategies, and invasive blood pressure monitoring to mitigate induction-phase hypotension.
Key Findings
- Prefrail and frail patients had higher IOH rates during surgery (IRR 1.09 and 1.16, respectively).
- During anesthesia induction, IOH increased by 28% in prefrail patients; frailty was linked to a 15% longer time-weighted IOH during induction.
- No difference in overall IOH likelihood or severity after accounting for duration, but mediation analysis suggested strong effects after adjusting for measurement frequency, surgical duration, and propofol dose.
Methodological Strengths
- Large cohort with standardized frailty assessment and regression modeling for multiple IOH metrics.
- Mediation analysis exploring measurement frequency, surgical duration, and anesthetic dosing.
Limitations
- Retrospective single-center design with potential unmeasured confounding.
- IOH defined by a single MAP threshold (<65 mm Hg) which may not capture individual variability.
Future Directions: Prospective trials to test frailty-tailored hemodynamic management (e.g., induction protocols, vasopressor algorithms) and evaluate organ outcomes.
BACKGROUND: Frailty is a predictor of morbidity and mortality in older patients. This study aimed to investigate the influence of frailty status on likelihood, rate, duration, and severity of intraoperative hypotension (IOH), which can lead to severe organ dysfunction. METHODS: Surgical patients (≥70 yr old) with preoperative frailty assessment were analysed retrospectively. Frailty status was defined as robust, prefrail, or frail based on modified Fried criteria. IOH was defined as mean arterial pressure <65 mm Hg. For likelihood, rate, duration, and severity of IOH, logistic and Poisson regression were used. RESULTS: We included 2495 patients. There was no significant difference in likelihood of IOH. An increase of 9% in rate of IOH during surgery for prefrail (incidence rate ratio [IRR] 1.09 [95% CI 1.03-1.16], P=0.002), and 16% increase for frail patients (IRR 1.16 [1.04-1.29], P=0.007) was observed. During anaesthesia induction, prefrail patients exhibited a 28% increase in IOH (IRR 1.28 [1.12-1.47], P<0.001). Although there were no differences in the severity of IOH if surgery or anaesthesia induction duration was taken into account, frailty status was associated with a 15% longer time-weighted duration of IOH during anaesthesia induction (IRR 1.15 [1.06-1.24], P=0.001). Mediator analysis revealed that frailty status accounted for >90% after considering number of measured blood pressures and surgical duration and >70% after accounting for total propofol dose. CONCLUSIONS: Prefrail and frail patients aged ≥70 yr experienced up to 16% more IOH during surgery and 28% more during anaesthesia induction compared with robust patients. Preoperative optimisation (prehabilitation) and modification of intraoperative management (e.g. invasive blood pressure management) have the potential to reduce IOH in prefrail and frail patients.